Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Neurological Sciences
Appendix
Available only for authorised users
Literature
1.
Taquet M, Sillett R, Zhu L, Mendel J, Camplisson I, Dercon Q, Harrison PJ (2022) Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry 9:815–827CrossRefPubMedPubMedCentral
2.
Zhang H, Zhou Z (2022) COVID-19 and the risk of Alzheimer’s disease, amyotrophic lateral sclerosis, and multiple sclerosis. Ann Clin Transl Neurol 9:1953–1961CrossRefPubMedPubMedCentral
3.
Baranova A, Cao H, Zhang F (2023) Causal effect of COVID-19 on Alzheimer’s disease: a Mendelian randomization study. J Med Virol 95:e28107CrossRefPubMed
4.
COVID-19 Host Genetics Initiative (2020) The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic. Eur J Hum Genet 28:715–718CrossRef
5.
Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, Sealock J, Karlsson IK, Hägg S, Athanasiu L et al (2019) Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nat Genet 51:404–413CrossRefPubMedPubMedCentral
Metadata
Title
Causal relationship of COVID-19 on Alzheimer’s disease: an updated Mendelian randomization study
Authors
Dongren Sun
Rui Wang
Ziyan Shi
Hongxi Chen
Hongyu Zhou
Publication date
15-04-2023
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 8/2023
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-023-06807-8

Other articles of this Issue 8/2023

Neurological Sciences 8/2023 Go to the issue

Letter to the Editor

Interleukin-17 inhibitors in myasthenia gravis: really bad or maybe good?

Original Article

IVIg-induced headache: prospective study of a large cohort with neurological disorders

Review Article

Leukoencephalopathy with calcifications and cysts: A case report with literature review

Original Article

Tolerability of clobazam as add-on therapy in patients aged 50 years and older with drug-resistant epilepsy

Original Article

Application of the “1-2-3-4-day” rule to stroke severity at baseline versus at 24 h to start direct oral anticoagulant for atrial fibrillation within 7 days from symptom onset

Original Article

BOLD fMRI and DTI fiber tracking for preoperative mapping of eloquent cerebral regions in brain tumor patients: impact on surgical approach and outcome